Dr. Lowensyein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St Philadelphia
Philadelphia, PA 19104Phone+1 215-662-3797
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 2013
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- PA State Medical License 2017 - 2026
- CA State Medical License 2015 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study.Margaret Lowenstein, M Holliday Davis, Shoshana V Aronowitz, Emily Seeburger, David Grande
Drug and Alcohol Dependence. 2025-01-29 - A qualitative study exploring the feasibility and acceptability of embedding an overdose prevention sites in a U.S. hospital.Rachel French, Rachal McFadden, Margaret Lowenstein, Nicole O'Donnell, Jeanmarie Perrone
Journal of Substance Use and Addiction Treatment. 2025-01-11 - Wound Characteristics Among Patients Exposed to Xylazine.Lydia Lutz, Rachel McFadden, Lin Xu, Ranvir Bhatia, M Holliday Davis
JAMA Dermatology. 2025-01-01
Press Mentions
- Telemedicine Program CareConnect Helps Eliminate Barriers for Opioid Use Disorder TreatmentNovember 16th, 2022
- Penn Medicine, Philadelphia Department of Public Health Partner to Increase Virtual Care for Patients with Opioid Use DisorderMay 5th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: